Download presentation
Presentation is loading. Please wait.
Published byCynthia Anderson Modified over 5 years ago
1
Model for end‐stage liver disease exception points for treatment‐responsive hepatocellular carcinoma
Treatment‐responsive HCC: patient with complete response to therapy 3 months after TACE. Arrow denotes pretreatment tumor (left) and response to therapy with lack of arterial enhancement (right). IF THIS IMAGE HAS BEEN PROVIDED BY OR IS OWNED BY A THIRD PARTY, AS INDICATED IN THE CAPTION LINE, THEN FURTHER PERMISSION MAY BE NEEDED BEFORE ANY FURTHER USE. PLEASE CONTACT WILEY'S PERMISSIONS DEPARTMENT ON OR USE THE RIGHTSLINK SERVICE BY CLICKING ON THE 'REQUEST PERMISSIONS' LINK ACCOMPANYING THIS ARTICLE. WILEY OR AUTHOR OWNED IMAGES MAY BE USED FOR NON-COMMERCIAL PURPOSES, SUBJECT TO PROPER CITATION OF THE ARTICLE, AUTHOR, AND PUBLISHER. Clinical Liver Disease, Volume: 7, Issue: 5, Pages: , First published: 27 May 2016, DOI: ( /cld.545)
Similar presentations
© 2024 SlidePlayer.com. Inc.
All rights reserved.